Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-03-013304
Filing Date
2003-12-02
Accepted
2003-12-01 17:56:37
Documents
10
Period of Report
2003-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K y92049e10vk.txt 10-K 426960
3 INDENTURE y92049exv4w9.txt EX-4.9 344610
4 REGISTRATION RIGHTS AGREEMENTS y92049exv4w11.txt EX-4.11 71266
5 EMPLOYMENT AGREEMENT y92049exv10w30.txt EX-10.30 51747
6 SUBSIDIARIES y92049exv21.txt EX-21 305
7 CONSENT OF KPMG LLP y92049exv23.txt EX-23 1744
8 CERTIFICATION OF CHIEF EXECUTIVE OFFICER y92049exv31w1.txt EX-31.1 3573
9 CERTIFICATION OF CHIEF FINANCIAL OFFICER y92049exv31w2.txt EX-31.2 3689
10 CERTIFICATION OF CHIEF EXECUTIVE OFFICER y92049exv32w1.txt EX-32.1 1492
11 CERTIFICATION OF CHIEF FINANCIAL OFFICER y92049exv32w2.txt EX-32.2 1524
  Complete submission text file 0000950123-03-013304.txt   909733
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 031030877
SIC: 2835 In Vitro & In Vivo Diagnostic Substances